Re-formulation of microbicidal lubricants will help protect from HIV
20 March 2017 | By Niamh Marriott, Junior Editor
Research published by BioMed Central’s open access journal AIDS Research and Therapy has investigated the use of lubricants...
List view / Grid view
News
Debiopharm’s triptorelin 6-month formulation receives EU approval
20 March 2017 | By Niamh Marriott, Junior Editor
Debiopharm International, a Swiss-based company, part of Debiopharm Group, announced that triptorelin 6-month formulation (Decapeptyl and Pamorelin 22.5 mg) received approval for the treatment of central precocious puberty (CPP) in 22 European countries, where the 6-month formulation has already been registered for the treatment of prostate cancer. Triptorelin is the…
Thermo Fisher Scientific acquires Core Informatics
Thermo Fisher Scientific Inc., the world leader in serving science, announced that it has acquired Core Informatics, which provides a leading cloud-based platform supporting scientific data management.
Honeywell Launches Double-Certified Reference Materials For Calibration Of Laboratory Instruments
17 March 2017 | By Honeywell
Honeywell announced the launch of its first series of Hydranal™ double-certified reference materials (CRM) for Karl Fischer Titration...
Honeywell Launches New Research Chemicals Business To Optimize Product Partnerships With Researchers
17 March 2017 | By Honeywell
Honeywell announced the launch of a new business, Honeywell Research Chemicals, that will now include several brands and solvent and inorganic chemical products that were acquired from Sigma-Aldrich in December 2015...
FPS will show the integrated solutions for jet mill, loop mill and mechanical mill: the multimilling platform
17 March 2017 | By F.P.S. Food and Pharma Systems Srl
At Interphex (21-23 March in New York, USA), FPS will show his last innovations in micronization and milling technologies, for pharmaceutical, cosmetic and chemical applications...
Study using Biocartis’ liquid biopsy assay shows new option for melanoma retreatment
17 March 2017 | By Niamh Marriott, Junior Editor
In a new study, advanced metastatic melanoma cancer patients that had become resistant to their BRAF-targeted treatment were given a retreatment...
Lynparza Phase III data demonstrates progression-free survival in ovarian cancer
17 March 2017 | By Niamh Marriott, Junior Editor
AstraZeneca’s Phase III SOLO-2 trial demonstrated a significant improvement in progression-free survival (PFS) in germline BRCA-mutated (gBRCA), platinum-sensitive, relapsed ovarian cancer patients treated with Lynparza (olaparib) tablets (300mg twice daily) compared with placebo in the maintenance setting. The trial met its primary endpoint of investigator assessed PFS (HR 0.30; 95%…
Syrris Orb batch reactors – designed for you
16 March 2017 | By Syrris
Syrris’ state-of-the-art Orb batch reactors are designed by chemists for chemists, ensuring they perfectly meet the demands of your work...
PharmaJet partners with Serum to launch needle-free MMR vaccine
16 March 2017 | By Niamh Marriott, Junior Editor
PharmaJet has partnered with Serum Institute of India to commercialise needle-free delivery of the MMR vaccine using the Stratis 0.5ml needle-free system...
NICE gets go-ahead to fast-track more drug approvals
15 March 2017 | By Niamh Marriott, Junior Editor
Patients are set to benefit from more rapid access to the most cost-effective treatments after proposed changes to the NICE drug evaluation process were approved...
Developing nanopreparation properties for use in anticancer medicines
15 March 2017 | By Steve Bremer, Managing Editor
Tumour therapy, particularly in the case of multidrug resistant cancers, could be significantly enhanced by using siRNA to down-regulate the production...
Biocartis and Merck partnership launch second liquid biopsy assay
15 March 2017 | By Niamh Marriott, Junior Editor
This collaboration is aimed at jointly developing and commercialising new liquid biopsy RAS biomarker tests for metastatic colorectal cancer (mCRC)...
Novartis’ Cosentyx shows almost all psoriasis patients rapidly regain skin clearance following a treatment pause
15 March 2017 | By Niamh Marriott, Junior Editor
Moderate-to-severe psoriasis patients treated with Cosentyx (secukinumab) rapidly regain clear skin following relapse during a treatment pause...
New economic data finds Novo Nordisk’s insulin degludec most cost effective diabetic treatment
14 March 2017 | By Niamh Marriott, Junior Editor
A new health economic analysis of two Phase 3b trials has demonstrated that Novo Nordisk's Tresiba is a cost-effective option for diabetes...
